Business Description
SMS Pharmaceuticals Ltd
ISIN : INE812G01025
Compare
Compare
Traded in other countries / regions
SMSPHARMA.India IPO Date
2007-02-28Description
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the manufacturing and sale of active pharmaceutical ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, among others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 2.54 | |||||
| Interest Coverage | 3.26 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.26 | |||||
| Beneish M-Score | -0.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.5 | |||||
| 3-Year EBITDA Growth Rate | -11.4 | |||||
| 3-Year FCF Growth Rate | -35.2 | |||||
| 3-Year Book Growth Rate | 9.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.02 | |||||
| 9-Day RSI | 60.47 | |||||
| 14-Day RSI | 62 | |||||
| 6-1 Month Momentum % | 55.65 | |||||
| 12-1 Month Momentum % | 118.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 0.65 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 219.57 | |||||
| Days Sales Outstanding | 78.99 | |||||
| Days Payable | 106.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.14 | |||||
| Dividend Payout Ratio | 0.07 | |||||
| 3-Year Dividend Growth Rate | -15.7 | |||||
| Forward Dividend Yield % | 0.14 | |||||
| 5-Year Yield-on-Cost % | 0.14 | |||||
| Shareholder Yield % | -0.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.8 | |||||
| Operating Margin % | 12.18 | |||||
| Net Margin % | 5.91 | |||||
| FCF Margin % | -1.22 | |||||
| ROE % | 7.77 | |||||
| ROA % | 3.98 | |||||
| ROIC % | 7.28 | |||||
| ROC (Joel Greenblatt) % | 10.7 | |||||
| ROCE % | 12.31 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 49.5 | |||||
| PE Ratio without NRI | 49.43 | |||||
| Shiller PE Ratio | 29.33 | |||||
| PS Ratio | 2.93 | |||||
| PB Ratio | 3.73 | |||||
| Price-to-Tangible-Book | 3.7 | |||||
| Price-to-Operating-Cash-Flow | 79.69 | |||||
| EV-to-EBIT | 25.91 | |||||
| EV-to-EBITDA | 18.4 | |||||
| EV-to-Revenue | 3.28 | |||||
| EV-to-FCF | -274.31 | |||||
| Price-to-Projected-FCF | 4.25 | |||||
| Price-to-Median-PS-Value | 2.05 | |||||
| Price-to-Graham-Number | 3.2 | |||||
| Price-to-Net-Current-Asset-Value | 802.69 | |||||
| Earnings Yield (Greenblatt) % | 3.86 | |||||
| FCF Yield % | -0.43 | |||||
| Forward Rate of Return (Yacktman) % | -3.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SMS Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,105.861 | ||
| EPS (TTM) (₹) | 4.27 | ||
| Beta | 0.75 | ||
| Volatility % | 48.8 | ||
| 14-Day RSI | 62 | ||
| 14-Day ATR (₹) | 11.222186 | ||
| 20-Day SMA (₹) | 198.74 | ||
| 12-1 Month Momentum % | 118.46 | ||
| 52-Week Range (₹) | 75.1 - 219.3 | ||
| Shares Outstanding (Mil) | 84.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SMS Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SMS Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
SMS Pharmaceuticals Ltd Frequently Asked Questions
What is SMS Pharmaceuticals Ltd(BOM:532815)'s stock price today?
The current price of BOM:532815 is ₹208.70. The 52 week high of BOM:532815 is ₹219.30 and 52 week low is ₹75.10.
When is next earnings date of SMS Pharmaceuticals Ltd(BOM:532815)?
The next earnings date of SMS Pharmaceuticals Ltd(BOM:532815) is .
Does SMS Pharmaceuticals Ltd(BOM:532815) pay dividends? If so, how much?
The Dividend Yield %  of SMS Pharmaceuticals Ltd(BOM:532815) is 0.14% (As of Today), Highest Dividend Payout Ratio of SMS Pharmaceuticals Ltd(BOM:532815) was 0.13. The lowest was 0.04. And the median was 0.05. The  Forward Dividend Yield % of SMS Pharmaceuticals Ltd(BOM:532815) is 0.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers